The most advanced meniscus care today is about saving the meniscus, not removing it: modern repair and root-repair techniques have strong evidence behind them, while many heavily marketed “regenerative” therapies are still unproven. This guide separates what works from what is still experimental, so you can make an informed decision.
Meniscus tears are among the most common knee injuries in athletes, active adults and people over 40. Hundreds of thousands of meniscus operations are performed every year in the United States alone, and treatment has changed considerably in the last decade. Here, the knee team at Sports Orthopedics Institute reviews the full range of options – from physiotherapy to root repair, transplantation and emerging biologics – and how strong the evidence is for each.
Key takeaways
- Degenerative tears in people over 45 usually do as well with structured physiotherapy as with keyhole surgery.
- Repairable tears in young, active people should be repaired, not removed, to protect the knee long term.
- Root tears need early recognition: repair gives far better long-term results than removal.
- PRP may modestly reduce repair failure when added to surgery, but evidence for PRP injections alone is limited.
- Stem cell and exosome injections for meniscus tears remain experimental, and in India stem cell use outside approved clinical trials is not permitted under ICMR guidelines.
How to read the evidence ratings in this guide
|
Rating |
What it means |
|---|---|
|
Strong |
Supported by randomised controlled trials or consistent high-quality meta-analyses |
|
Moderate |
Supported by multiple comparative studies with consistent findings |
|
Limited |
Small or mixed studies; benefit possible but not established |
|
Experimental |
Laboratory, animal or early-phase human trials only; not standard care |
Understanding the Meniscus
Each knee has two C-shaped cartilage cushions – the medial (inner) and lateral (outer) meniscus – that absorb shock, spread load, stabilise the joint and protect the joint cartilage.
Blood supply decides healing
Only the outer 10–30% of the meniscus (the red zone) has a good blood supply and heals reliably after repair. The middle red-white zone has some healing potential, while the inner white zone has no blood vessels and rarely heals on its own.
Types of meniscus tear
|
Tear type |
Description |
Healing potential |
|---|---|---|
|
Vertical longitudinal (bucket-handle when large and displaced) |
Runs along the meniscus fibres |
Good, especially in the red zone; often repairable |
|
Radial |
Runs from the inner edge towards the rim, cutting across the load-bearing fibres |
Poor if left; complete radial tears now often repaired |
|
Horizontal |
Splits the meniscus into upper and lower layers |
Common in degenerative knees; variable |
|
Complex |
A combination of patterns, often degenerative |
Usually poor |
|
Root tear |
Tear at or near the meniscus's attachment to the bone |
Functionally like losing the whole meniscus; repair recommended where suitable |
Why Treatment Has Shifted Towards Saving the Meniscus
Removing meniscus tissue (meniscectomy) relieves symptoms in the short term but increases the load on the joint cartilage, raising the risk of osteoarthritis over the following 10–20 years. This is why surgeons now repair whenever a tear is repairable.
The evidence on degenerative tears
For degenerative tears in middle-aged and older adults, high-quality trials have changed practice. The Dutch ESCAPE trial randomised 321 patients aged 45–70 to keyhole partial meniscectomy or exercise-based physiotherapy. At five years, physiotherapy was no worse than surgery for knee function, and the authors concluded it should be the preferred first treatment (JAMA Network Open, 2022). A Norwegian trial in patients averaging 49.5 years found similar results at two years.
What this means for you: if you are over about 45 with a degenerative tear and no true locking, a supervised exercise programme is usually the right first step. Surgery is reserved for persistent mechanical symptoms or failure of a proper rehab trial.
Evidence at a Glance
The treatments with the strongest evidence are often the least glamorous: physiotherapy for degenerative tears and surgical repair for repairable ones.
|
Treatment |
Best suited for |
Evidence |
Status |
|---|---|---|---|
|
Structured physiotherapy |
Degenerative tears, age 45+ |
Strong |
Standard first-line care |
|
Arthroscopic meniscus repair |
Repairable tears in young, active patients |
Strong |
Standard care |
|
Meniscus root repair |
Root tears with little arthritis |
Moderate |
Standard care |
|
Partial meniscectomy |
Unrepairable tears with true mechanical symptoms |
Moderate |
Standard care, used selectively |
|
Meniscal allograft transplantation |
Young patients with pain after prior meniscectomy |
Moderate |
Specialist procedure; donor tissue availability limited in India |
|
PRP added to surgical repair |
Augmenting a repair |
Limited |
Optional add-on |
|
PRP injection alone |
Selected degenerative tears |
Limited |
Optional, not a substitute for rehab |
|
Marrow venting at the time of repair |
Augmenting a repair |
Limited |
Optional add-on |
|
Synthetic meniscus implants |
Pain after meniscectomy |
Limited |
Available in some countries; not FDA-approved |
|
Stem cell injections (bone marrow, fat, cord) |
– |
Limited / Experimental |
Clinical trials only in India |
|
Exosome injections |
– |
Experimental |
No approved products |
|
3D-printed hydrogels, AM3101, gene therapy |
– |
Experimental |
Laboratory or early clinical trials |
Surgical Advances
Arthroscopic meniscus repair
Keyhole repair stitches the torn edges together through 5–8 mm incisions, preserving the knee's natural cushion. With appropriate tears – typically vertical tears in the red zone – healing rates of roughly 70–90% are reported.
- All-inside repair: sutures are placed entirely through the arthroscope using specialised implant devices, with no extra incisions. Quick and widely used for tears at the back of the meniscus.
- Inside-out repair: sutures pass from inside the joint and are tied through a small incision at the back or side of the knee. Very strong; often used for larger and posterior tears.
- Outside-in repair: sutures pass from outside the knee into the joint. Well suited to tears at the front of the meniscus.
What improves healing: younger age, tears near the rim, vertical tear patterns, acute rather than long-standing tears, not smoking, and having the repair at the same time as an ACL reconstruction (the bone tunnels release healing factors into the joint).
Meniscus root repair
A root tear disconnects the meniscus from the bone, so it can no longer hold load – and the evidence for repairing it is now compelling. The meniscus is reattached either with sutures pulled through a tunnel in the shin bone (transtibial pull-out) or with suture anchors.
A 10-year cohort study found that 56% of patients treated with partial meniscectomy for a medial root tear needed a knee replacement, compared with 22% after root repair (American Journal of Sports Medicine). A 2026 meta-analysis of studies with over five years' follow-up found meniscectomy carried around ten times the odds of failure and conversion to knee replacement compared with repair (Orthopaedic Journal of Sports Medicine). Most of this evidence is observational, but it is consistent. Early diagnosis matters, because repair works best before significant arthritis develops.
Nano-arthroscopy
Newer needle-sized arthroscopes (around 2 mm) allow some diagnostic and selected therapeutic procedures through even smaller incisions, sometimes in an outpatient setting. The technology is promising, but evidence comparing it with standard arthroscopy for meniscus repair is still limited.
When the Meniscus Is Already Lost: Transplants and Implants
Meniscal allograft transplantation
For young patients with persistent pain after a previous meniscectomy, a donor meniscus can be sized and implanted to restore cushioning. It is fixed with bone plugs, a bone bridge or sutures. Good-to-excellent results are reported in a majority of well-selected patients.
Ideal candidates are usually under about 50, with pain in the meniscus-deficient compartment, little arthritis, and a stable, well-aligned knee (or one corrected at the same time). They must be prepared for a long rehabilitation. In India, availability of sized donor menisci is limited, which affects access.
Synthetic meniscus implants
- Scaffold implants (collagen-based or polyurethane) are designed to fill a partial meniscus defect and let new tissue grow in. Evidence is limited and results vary.
- The NUsurface polymer meniscus replacement has been marketed in parts of Europe and Israel and received FDA Breakthrough Device designation (MedTech Dive). However, in 2023 an FDA advisory panel voted 6–2 that its benefits did not outweigh its risks (BioWorld), so it is not approved in the US.
Biologic Treatments: PRP, Stem Cells and Exosomes
Biologics are an exciting area of research, but their evidence for meniscus tears ranges from limited to experimental – and the marketing often runs well ahead of the science.
Platelet-rich plasma (PRP)
PRP is made by spinning a sample of your own blood to concentrate the platelets, which release growth factors involved in healing.
- As an add-on to surgical repair: several meta-analyses report fewer repair failures with PRP. One 2022 analysis found lower failure rates and slightly better pain scores, but noted there was not enough randomised trial evidence to firmly recommend it (Journal of Orthopaedic Surgery and Research). Another meta-analysis found no difference in failure or function (Journal of Orthopaedics and Traumatology). Rating: Limited – a reasonable option to discuss, not a must.
- As an injection alone: some patients with degenerative tears report symptom relief, but good-quality trials are few. It should complement, not replace, a structured exercise programme.
Marrow venting
Small holes made in the nearby bone during repair release blood and marrow cells into the joint, similar to the healing boost seen when meniscus repair is combined with ACL reconstruction. It is simple and low-cost, but evidence is limited.
Stem cell therapy
Bone marrow concentrate, fat-derived cells and umbilical cord-derived cells have shown encouraging results in small studies, but there are no large, high-quality trials proving they heal meniscus tears.
The regulatory position in India is clear. The ICMR–DBT National Guidelines for Stem Cell Research state that, apart from approved blood-forming stem cell transplants, stem cell use in patients is investigational and should only take place within an approved and monitored clinical trial (Nature India). If a clinic offers stem cell injections for a meniscus tear as routine paid treatment, ask whether it is part of a registered clinical trial.
Exosome therapy
Exosomes are tiny vesicles released by cells that carry signalling molecules. The idea is appealing, but human evidence in orthopaedics is extremely thin. The US FDA states that there are currently no approved exosome products and has warned about adverse events from unapproved products (US FDA). Rating: Experimental – not a treatment we recommend outside research.
The Experimental Frontier
These developments are genuinely promising, but none is yet available as routine treatment.
3D-printed customisable hydrogel
Researchers at the University of Pennsylvania developed a 3D-printed hydrogel made from decellularised cow meniscus, which can be tuned to match the stiffness of different zones of the meniscus. The work is pre-clinical: it performed well in small-animal studies, and the team is moving to large-animal models, with smaller localised tears as the first clinical target (Penn Medicine, 2025).
AM3101 injectable drug
AM3101, developed by Amplicore with the University of Cincinnati, is an injection given next to a meniscus repair to create a more favourable healing environment. The FDA cleared its investigational new drug application, allowing a Department of Defense-funded Phase 1/2 trial of 74 patients comparing repair plus AM3101 with repair alone (University of Cincinnati). Results are awaited; it is an investigational add-on to surgery, not a replacement for it.
Further on the horizon
- Gene therapy to boost the healing capacity of meniscus cells
- Tissue engineering of meniscus grown from a patient's own cells
- “Smart” scaffolds combining biodegradable materials, growth factors and cells
- Artificial intelligence to read MRI scans and predict which tears will heal with which treatment
All remain at the research stage.
Rehabilitation: The Treatment Behind Every Treatment
Whatever option you choose, a structured rehab programme is what restores strength and protects the knee. Timelines below are typical for conservative care or meniscus repair; your surgeon may adjust them, especially after root repair or transplantation.
|
Phase |
Timing |
Focus |
|---|---|---|
|
Early |
Weeks 0–6 |
Protect healing tissue (crutches, brace, weight-bearing and bending limits as advised); control swelling with ice, compression and elevation; gentle pain-free movement; quadriceps activation and isometrics |
|
Intermediate |
Weeks 6–12 |
Progressive strengthening of quadriceps, hamstrings, hips and core; balance and proprioception work; controlled squats, lunges and step-downs; low-impact cardio such as cycling and swimming |
|
Advanced |
Months 3–6 |
Sport-specific training; jumping, landing and cutting drills; agility work; return to sport guided by strength testing, hop tests and movement quality |
After a partial meniscectomy, return to activity is usually faster, often around 6–8 weeks.
Choosing the Right Treatment
The decision rests on the tear, the knee and the person – not on which technology is newest.
|
Factor |
Favours repair or preservation |
Favours conservative care or limited meniscectomy |
|---|---|---|
|
Tear location |
Outer red zone |
Inner white zone |
|
Tear pattern |
Vertical, bucket-handle, root, complete radial |
Degenerative horizontal or complex |
|
Age and activity |
Under about 40, active or athletic |
Older, lower demand |
|
Timing |
Acute (recent) tear |
Long-standing degenerative tear |
|
Associated injury |
ACL tear being reconstructed |
Established arthritis |
|
Symptoms |
Locking, displaced fragment |
Pain and swelling without true locking |
When watchful waiting makes sense
Many degenerative tears cause mild symptoms that settle with time and exercise. A conservative approach is reasonable if symptoms are tolerable, daily life is not significantly limited, the knee feels stable and X-rays show little arthritis.
Conservative care includes: activity modification, a supervised strengthening programme, short courses of anti-inflammatory medicines, a supportive or unloader brace, and weight management.
Seek further treatment if: symptoms worsen despite rehab, the knee locks, catches or gives way, or pain significantly affects your quality of life.
Cost considerations
In general, physiotherapy is the least expensive option, PRP costs more and may need repeat sessions, arthroscopic repair costs vary with complexity and implants, and transplantation is the most expensive. Regenerative injections are usually not covered by insurance. Your exact estimate is personalised after evaluation.
Prevention
- Keep the quadriceps, hamstrings, hips and core strong
- Learn good technique for pivoting, cutting and landing
- Increase training load gradually rather than in sudden jumps
- Warm up properly and allow recovery between sessions
- Wear appropriate, supportive footwear
- Maintain a healthy body weight
How Sports Orthopedics Institute Can Help
We offer the full range of evidence-based meniscus care – from structured physiotherapy to complex repairs – and we tell you honestly where the evidence stands.
- Accurate diagnosis: clinical examination and MRI review to define the tear type, location and repairability.
- Meniscus preservation first: all-inside, inside-out and outside-in repair, and root repair, when your tear is repairable.
- Shared decision-making: clear explanations of the benefits, risks, costs and evidence for each option, including biologics.
- Integrated rehabilitation: criteria-based programmes that take you from protection to full return to sport.
Knee pain, swelling, catching or locking? Book a consultation with our knee specialists in Bengaluru for an expert evaluation and a treatment plan built around your goals.
Frequently Asked Questions
Can a meniscus tear heal without surgery?
Some can. Small tears in the outer red zone may heal, and degenerative tears in people over 45 often settle well with structured physiotherapy. Large, displaced or unstable tears and those causing true locking usually need surgery.
What is the best treatment for a torn meniscus?
It depends on the tear and the person. For young, active patients with a repairable tear, arthroscopic repair is best for long-term knee health. For degenerative tears in older adults, physiotherapy is the evidence-based first step. Root tears should be assessed early for repair.
How long does a torn meniscus take to heal?
With conservative care, symptoms often improve in 6–12 weeks. After repair, full recovery and return to sport usually take 4–6 months. After a partial meniscectomy, return to activity is often around 6–8 weeks.
What is the difference between meniscus repair and meniscectomy?
Repair stitches the tear to keep the meniscus, which protects the knee long term but needs a longer recovery. Meniscectomy removes the damaged part for quicker relief but increases the long-term risk of arthritis. Repair is preferred whenever possible.
What is the success rate of meniscus repair?
Roughly 70–90% for well-selected tears. Success is higher in younger patients, peripheral and vertical tears, acute tears, non-smokers, and when the repair is done with an ACL reconstruction.
Is PRP effective for meniscus tears?
The evidence is limited. When added to surgical repair, some studies suggest fewer failures; others show no difference. As an injection on its own, it may help symptoms in some degenerative tears but should not replace rehab.
Are stem cell injections approved for meniscus tears in India?
No. Under ICMR–DBT national guidelines, stem cell use for conditions such as meniscus tears is investigational and should only be done within an approved clinical trial, not offered as routine paid treatment.
Is walking good for a torn meniscus?
Gentle walking is usually fine if it does not cause significant pain, catching or locking. Early after an injury or repair, crutches and limited weight-bearing may be needed. Your physiotherapist will guide how quickly to increase distance.
What happens if a torn meniscus is left untreated?
Many small or degenerative tears settle. Others can cause ongoing pain, swelling, catching or locking, and some – especially root tears – speed up cartilage wear and arthritis. Get a specialist assessment if symptoms persist.
What are the symptoms of a torn meniscus?
Pain along the joint line, swelling over hours to days, stiffness, difficulty fully straightening the knee, pain with twisting, and catching, locking or giving way.
How do I know if I need surgery?
Surgery is considered if you have true locking or a displaced tear, a repairable tear and an active lifestyle, a root tear, or symptoms that persist despite 6–12 weeks of proper rehab.
References
- Noorduyn JCA et al. Physical therapy vs arthroscopic partial meniscectomy in degenerative meniscal tears: 5-year follow-up of the ESCAPE trial. JAMA Network Open, 2022.
- Cohort study: Meniscectomy vs pull-out repair for medial meniscus posterior root tears: minimum 10-year follow-up. American Journal of Sports Medicine, 2020.
- Medial meniscus root repair vs partial medial meniscectomy at minimum 5 years: systematic review and meta-analysis. Orthopaedic Journal of Sports Medicine, 2026.
- Li Z, Weng X. Platelet-rich plasma use in meniscus repair: systematic review and meta-analysis. Journal of Orthopaedic Surgery and Research, 2022.
- PRP augmentation does not result in more favourable outcomes in arthroscopic meniscal repair: a meta-analysis. Journal of Orthopaedics and Traumatology, 2022.
- ICMR–DBT National Guidelines for Stem Cell Research, 2017 (Nature India summary).
- US FDA. Consumer alert on regenerative medicine products including stem cells and exosomes.
- Penn Medicine. Meniscus injuries may soon be treated by customizable hydrogel, 2025.
- University of Cincinnati. UC begins DOD-funded clinical trials with Amplicore, 2023.
- BioWorld. Active Implants back to the drawing board after FDA hearing for NUsurface, 2023.
Disclaimer: This article is for information only and does not constitute medical advice. Always consult a qualified orthopedic specialist for diagnosis and treatment of your condition.